Rohto Pharmaceutical and Euglena Conclude a Capital and Business Alliance Agreement
Rohto Pharmaceutical and euglena have signed a capital and business alliance agreement to realize a sustainable society.
Combining the strengths of Rohto Pharmaceutical, which has developed eye care, skin care, and oral medicine businesses mainly in the health and beauty care field, with the strengths of Euglena Co., Ltd., which has developed a healthcare business and a biofuel business using the microalgae Euglena, Promote collaboration in various business areas and research and development.
Comments
Post a Comment